Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 8 | 0 | 0 | 8 |
SMAD family member 2 | 10 | 0 | 0 | 10 |
SMAD family member 3 | 10 | 0 | 0 | 10 |
AR protein | 34 | 0 | 0 | 34 |
retinoid X nuclear receptor alpha | 17 | 0 | 0 | 17 |
estrogen-related nuclear receptor alpha | 32 | 0 | 0 | 32 |
farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
estrogen nuclear receptor alpha | 35 | 0 | 0 | 35 |
peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
peroxisome proliferator activated receptor gamma | 21 | 0 | 0 | 21 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 19 | 0 | 0 | 19 |
thyroid hormone receptor beta isoform a | 12 | 0 | 0 | 12 |
thyroid hormone receptor beta isoform 2 | 22 | 0 | 0 | 22 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 23 | 0 | 0 | 23 |
Androgen receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 11 | 3 | 15 |
5-hydroxytryptamine receptor 1B | 0 | 7 | 1 | 8 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 8 | 1 | 9 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 9 | 0 | 0 | 9 |
Thymidine kinase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 13 | 0 | 0 | 13 |
phosphopantetheinyl transferase | 9 | 0 | 0 | 9 |
GLS protein | 8 | 0 | 0 | 8 |
TDP1 protein | 30 | 0 | 0 | 30 |
Smad3 | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
arylsulfatase A | 11 | 0 | 0 | 11 |
euchromatic histone-lysine N-methyltransferase 2 | 22 | 0 | 0 | 22 |
activating transcription factor 6 | 14 | 0 | 0 | 14 |
Histone H2A.x | 10 | 0 | 0 | 10 |
Bloom syndrome protein isoform 1 | 11 | 0 | 0 | 11 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 20 | 0 | 0 | 20 |
Solute carrier family 22 member 1 | 0 | 7 | 0 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 14 | 0 | 14 |
Multidrug resistance-associated protein 4 | 0 | 14 | 0 | 15 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Bile salt export pump | 0 | 24 | 0 | 24 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 7 | 1 | 8 |
Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 14 | 0 | 15 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 27 | 0 | 0 | 27 |
nuclear receptor subfamily 1, group I, member 3 | 23 | 0 | 0 | 23 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 17 | 0 | 0 | 17 |
glucocorticoid receptor [Homo sapiens] | 23 | 0 | 0 | 23 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 10 | 0 | 0 | 10 |
heat shock protein beta-1 | 11 | 0 | 0 | 11 |
importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
snurportin-1 | 4 | 0 | 0 | 4 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 12 | 0 | 0 | 12 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 12 | 0 | 0 | 12 |
Ataxin-2 | 14 | 0 | 0 | 14 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 9 | 0 | 0 | 9 |
GLI family zinc finger 3 | 25 | 0 | 0 | 25 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 22 | 0 | 0 | 22 |
IDH1 | 11 | 0 | 0 | 11 |
chromobox protein homolog 1 | 14 | 0 | 0 | 14 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
geminin | 24 | 0 | 0 | 24 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 2 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 4 | 3 | 8 |
Spike glycoprotein | 14 | 0 | 1 | 15 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
67.9K protein | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit delta | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 7 | 4 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 7 | 4 | 19 |
Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 7 | 4 | 19 |
GABA theta subunit | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid receptor subunit epsilon | 8 | 7 | 3 | 18 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 7 | 4 | 11 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 7 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 7 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 6 | 4 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 6 | 3 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 6 | 3 | 9 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 6 | 3 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 6 | 0 | 6 |
aldehyde dehydrogenase 1 family, member A1 | 17 | 0 | 0 | 17 |
thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
Cellular tumor antigen p53 | 24 | 0 | 0 | 24 |
Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
interleukin 8 | 4 | 0 | 0 | 4 |
pregnane X receptor | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 9 | 0 | 0 | 9 |
progesterone receptor | 15 | 0 | 0 | 15 |
bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
plasminogen precursor | 5 | 0 | 0 | 5 |
urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 10 | 0 | 0 | 10 |
USP1 protein, partial | 11 | 0 | 0 | 11 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
Vpr | 3 | 0 | 0 | 3 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 2 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 5 | 0 | 7 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 9 |
Sodium channel protein type 9 subunit alpha | 0 | 5 | 0 | 5 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 5 | 7 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 2 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
estrogen receptor 2 (ER beta) | 11 | 0 | 0 | 11 |
caspase-3 | 6 | 0 | 0 | 6 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
Chain A, Cruzipain | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
Beta-1 adrenergic receptor | 0 | 1 | 2 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 6 | 3 | 10 |
Alpha-1B adrenergic receptor | 0 | 11 | 1 | 12 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 5 | 3 | 9 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 5 | 1 | 6 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
Alpha-2C adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-2A adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-1D adrenergic receptor | 0 | 8 | 1 | 9 |
Alpha-1D adrenergic receptor | 0 | 2 | 2 | 5 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A2a | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 2 | 3 | 6 |
Alpha-1B adrenergic receptor | 0 | 1 | 2 | 4 |
Alpha-1A adrenergic receptor | 0 | 11 | 2 | 13 |
Histamine H2 receptor | 8 | 1 | 0 | 10 |
5-hydroxytryptamine receptor 7 | 0 | 5 | 0 | 5 |
D(2) dopamine receptor | 0 | 3 | 1 | 4 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Nischarin | 0 | 1 | 0 | 1 |
Luciferase | 9 | 0 | 0 | 9 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 6 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-galactosidase | 0 | 1 | 0 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 8 | 0 | 0 | 8 |
G | 13 | 0 | 0 | 13 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
Interferon beta | 14 | 0 | 0 | 14 |
HLA class I histocompatibility antigen, B alpha chain | 13 | 0 | 0 | 13 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Translocator protein | 0 | 1 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 13 | 0 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 13 | 0 | 0 | 13 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 3 | 1 | 4 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 10 | 0 | 10 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Adenosine receptor A3 | 0 | 5 | 1 | 6 |
Cytochrome P450 2D6 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 7 |
Beta-3 adrenergic receptor | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 1 | 6 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 10 | 1 | 11 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 1 | 7 |
5-hydroxytryptamine receptor 2C | 0 | 7 | 1 | 8 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 7 | 0 | 7 |
Alpha-synuclein | 4 | 2 | 0 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 12 | 1 | 13 |
5-hydroxytryptamine receptor 6 | 0 | 5 | 1 | 6 |
Sodium-dependent dopamine transporter | 0 | 7 | 0 | 7 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 10 | 0 | 10 |
Hsf1 protein | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
Taste receptor type 2 member 38 | 0 | 0 | 0 | 1 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 0 | 1 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 4 | 1 | 6 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 1 | 8 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 4 |
Caspase-3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 4 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 4 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
D(2) dopamine receptor | 0 | 5 | 1 | 6 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 4 | 1 | 5 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 5 | 2 | 7 |
Delta-type opioid receptor | 0 | 5 | 2 | 7 |
Kappa-type opioid receptor | 0 | 5 | 1 | 6 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
GALC protein | 4 | 0 | 0 | 4 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 5 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
Oleandomycin glycosyltransferase | 0 | 0 | 0 | 1 |
Chain A, Purine-nucleoside Phosphorylase | 0 | 1 | 0 | 1 |
Chain C, Xanthine dehydrogenase/oxidase | 0 | 0 | 1 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Snq2p | 0 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 2 | 1 | 4 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 3 | 1 | 5 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 6 | 0 | 6 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Transporter | 0 | 3 | 0 | 3 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
matrix metalloproteinase 1, partial | 0 | 0 | 1 | 1 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
PPM1D protein | 4 | 0 | 0 | 4 |
Thrombopoietin | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 5 | 0 | 0 | 5 |
polyprotein | 3 | 0 | 0 | 3 |
Parkin | 4 | 0 | 0 | 4 |
P53 | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
flap endonuclease 1 | 7 | 0 | 0 | 7 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
Menin | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 3 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 5 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Calmodulin | 0 | 1 | 1 | 2 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
PINK1 | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
Glucocorticoid receptor | 0 | 4 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 2 | 4 |
Androgen receptor | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 1 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
endonuclease IV | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Adenosine receptor A2a | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 2 | 1 | 4 |
Thymidine phosphorylase | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 0 | 2 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 4 | 6 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |